OHSU

IRB #

IRB00009885

Title

Safety and Efficacy of A Lysophosphatidic Acid Receptor
Antagonist in Idiopathic Pulmonary Fibrosis
IM136003

Principal Investigator

Akram Khan

Study Purpose

The purpose of this study is to test the effectiveness of an investigation drug at slowing the decline of lung function in individuals with pulmonary fibrosis by comparing two different doses of the drug vs placebo.

Medical Condition(s)

Pulmonary Fibrosis

Eligibility Criteria

You must be between the ages of 40 and 80 and have had symptomatic pulmonary fibrosis for at least 12 months before enrollment into the study.

Age Range

40 - 90

Healthy Volunteers Needed

No

Duration of Participation

26 months

Minors Included

No

Contact

Nathan Kessler: 503-494-9570, Kesslena@ohsu.edu

Sponsor

Bristol Myers Squibb Company

Recruitment End

Compensation Provided

No


Go Back